I can see where you are coming from. But there are roughly 700 million who could be classed as the middle class in China with excellent hospitals throughout the country which could easily afford the product. These patients needing PNV products can't all head over to Hong Kong for treatment even though the hospitals and patients have the financial capability.
No doubt the company is working on it and things are being put in place as quickly and efficiently as possible. Look forward to updates though 2024 on this. Japan - ?? Apparently their bodies are different, so things need to be double and triple checked to what happens, as thorough testing and extensive multiple studies that have been done by 'gaijins' is not worth giving any credibility (note sarcasm)!
I can see where you are coming from. But there are roughly 700...
-
- There are more pages in this discussion • 1,198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.57 |
Change
0.030(1.18%) |
Mkt cap ! $1.773B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.60 | $2.55 | $1.327M | 514.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2507 | $2.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 4000 | 2 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |